INTRODUCTION
Spondyloarthritis (SpA) is a family of immune-mediated inflammatory disorders that includes ankylosing spondylitis (AS), psoriatic arthritis (PsA), juvenile spondyloarthritis (JSpA), and acute anterior uveitis. Undifferentiated SpA is now classified as axial or predominantly peripheral. There is considerable clinical overlap between SpA and inflammatory bowel disease (IBD), with IBD and AS exhibiting shared genetic predisposition and pathogenic mechanisms. IBD has been long associated with alterations in the gut microbiome, which may be primary or secondary factors in disease pathogenesis [1] .
Rats overexpressing HLA-B27 spontaneously develop an inflammatory disease exhibiting arthritis and colitis, thus, mimicking human SpA [2] . In common with the vast majority of IBD animal models, disease development in this model is microbiota dependent [3] . Rosenbaum and Davey [4] proposed that HLA-B27 alters the intestinal microbiome, which might be the basis for disease predisposition associated with this allele. This concept is supported by theories of a disrupted gut environment in spondyloarthropathy, with altered intestinal permeability perhaps leading to a dysregulated immune response and/or altered dendritic-cell function. This may then drive microbial dysbiosis and/or microbiotamediated intestinal inflammation leading to epithelial permeability. Here, we review recent developments from studies of the gut microbiome in patients with AS, JSpA, and PsA as well as insights obtained from the animal models of SpA.
THE GUT MICROBIOTA
The gut microbiota is the vast microbial community that inhabits our intestine. Microbial cells outnumber host cells by a factor of 10, and collectively harbor 100-fold more genes than the human genome [5] . Staggeringly, an estimated 10% of all the metabolites in humans are thought to have microbial origins [6] . This mutually beneficial relationship offers host nutrients to intestinal commensal bacteria, in return for metabolic and physiological capabilities. Cohabitation with microbes seems to be an ever-evolving process with host microbe crosstalk normally involving regulation of immune activation and inflammation [7] . Although the microbiome varies between individuals, familial, and functional similarities are found in the bacterial species represented [8] . Gut microbiome analysis in healthy human populations revealed around 1150 species of bacteria, the majority of which (50-75%) are represented by Firmicutes, followed by Bacteroidetes (10-50%), and Actinobacteria (1-10%), with less than 1% being Proteobacteria [9] . Environmental factors and host genome have both been implicated as contributing to this similarity. The advent of high throughput genome sequencing techniques such as next-generation 16S rRNA sequencing has led to crucial insights into the intestinal metagenome, as more than 70% of the bacterial population including many anaerobes cannot be readily cultured [9] . The ability to routinely obtain an unbiased assessment of gut microbiota has resulted in a more comprehensive view of the gut dysbiosis in SpA patients as well as HLA-B27-driven disease in an animal model. Table 1 [10 -16,17 & ,18-22] refers to studies implicating gut bacteria in human diseases and animal models of spondyloarthropathies.
ANIMAL MODELS OF SPONDYLOARTHRITIS
Gut commensals are important for educating our immune system, as animals raised in germ-free environments fail to develop lymphoid organs and have muted adaptive immunity [23] . Thus, it is not surprising to think that more subtle differences in microbial communities might influence (or be influenced by) autoimmune or autoinflammatory diseases. In HLA-B27 transgenic rats that develop SpA, inflammatory disease features including arthritis and colitis are absent when animals are derived into a germ-free environment [3] . Interestingly, reintroduction of normal flora enables the inflammatory disease to reestablish itself [24] . Although these early studies clearly established a role for the gut microbiome in SpA, more recent work has focused on defining the differences. HLA-B27 transgenic rats have a different cecal microbiome as compared with the wild-type (WT) (nontransgenic) rats [25 && ]. How this affects immune modulation and disease severity is not clear. This study [25 && ] found increases in Prevotellaceae and Rikenellaceae concomitant with development of inflammation in the intestine.
Recent murine experiments have demonstrated that overall microbial composition as well as individual species plays an important role in development of inflammatory arthritis. Intestinal segmented filamentous bacteria (SFB) [26 & ] colonization of germ-free K/B x N mice was sufficient to drive arthritis development [27] . SFB colonization in the gut induced secondary and tertiary lymphoid tissues to generate IgA and Th17 T-cell responses [28 & ]. Notably, SFB antigen presentation by intestinal dendritic cells (CD11c þ ) is crucial for the development of Th17 cells, evoking a highly SFB-specific Th17 response [26 & ]. These observations provide
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mechanistic support for earlier research suggesting that mucosal T cells are modulated by gut bacterial components [29] , as well as outline the complex interplay between dendritic cells and innate lymphoid cells in regulating intestinal Th17-cell homeostasis. A common feature of SFB and other intestinal microbes that strongly potentiate Th17 responses such as Citrobacter rodentium is their intimate association/attachment to intestinal epithelial cells. This is consistent with the notion that mucosaassociated bacteria may be particularly relevant to IBD and/or SpA pathogenesis. Another bacteria associated with SpA (reactive arthritis), Chlamydia trachomatis, has been associated with induction of interleukin 23 (IL-23) expression in infected target cells [18] . Polymorphisms in the IL-23 receptor (IL23R) have been associated with AS and IBD [30] , and the IL-23 interaction with IL23R promotes the expansion of Th17 cells, and is a direct stimulator of Th17 cytokine production [31] . In the BALB/c background mutant mice, designated as the SKG mice, SKG mouse, which is a model of SpA, T-cell receptor [32] signaling strength is impaired due to a mutation in ZAP-70. This results in the development and expansion of CD4 þ Th17 T cells. When these mice are treated with microbeassociated molecular patterns such as curdlan, which is a strong inducer of IL-23, there is tremendous Th17 activation and a strong inflammatory response that produces a SpA-like phenotype. Although germ-free conditions ameliorate arthritis and ileitis, cohousing SKG mice with WT mice suppressed the ileitis but did not attenuate arthritis, suggesting that host microbiome interactions play a role in IL-23-dependent loss of mucosal function in SKG mice, triggering ileitis in response to curdlan [33 & ]. Animal models of IBD and SpA have also provided novel insight at antiinflammatory pathways elicited by the intestinal microbiota. The mucosal lining of the lumen has emerged as an important component of host-microbe interaction. Epithelial fucosylation helps promote commensal colonization, at the same time resisting pathogens in the mucosal lining [34] . Another emerging area is the action of short chain fatty acids (SCFAs), fermentation products of gut microbes whose production is enriched in mucus degrading bacteria [35] . One such SCFA, butyrate, regulates intestinal permeability [36] . Low doses of butyrate enhance barrier function, whereas high doses increase intestinal permeability, probably secondary to cell death [37] . Atarashi and coworkers [38, 39] demonstrated that gnotobiotic mice colonized with Clostridium leptum and Clostridium coccoides have enhanced accumulation of Tregs in colonic lamina propria.
They showed that Clostridium groups activate colonic intestinal epithelial cells to produce Transforming growth factor beta (TGF-b) TGF-b and other Treg-inducing molecules. Administration of diets that are rich in SCFA like butyrate to mice, or the administration of butyrate itself to naive CD4 þ cells, can promote their differentiation to colonic Tregs [40, 41] . The myriad reported antiinflammatory effects of SCFA also extend to imparting antiinflammatory effects on intestinal antigen presenting cells (APC) [42] . Potential therapeutic effects warrant further scrutiny in SpA animal models or patient populations [43] .
ANKYLOSING SPONDYLITIS
A recent study [44 & ] revealed distinct microbial colonization in the terminal ileum of a small number of patients with AS, using healthy individuals as controls. There was an increase in the abundance of Lachnospiraceae, Ruminococcaceae, and Prevotellaceae in AS patients. Interestingly, these bacterial species are also observed in the Dextran Sulphate Sodium (DSS) DSS-induced colitis model of mice [45] . Although the authors saw a decreased abundance of Streptococcus and Actinomyces in comparison to the control population, they did not see any differences in the bacteria normally associated with reactive arthritis or even Klebsiella species, which have been hypothesized to trigger AS [46] .
A study [47] comparing certain gut microbes in AS patients with age-matched controls revealed an increase in sulphate reducing Bacteriodes in patients. In a follow-up study [48] with AS patients and healthy controls, these authors reported that reduced levels of IL-10 production upon stimulation of their PBMCs with autologous Bacteroides. Previous studies in HLA-B27 transgenic rats [24] also reported that recolonization of the gut of germ-free animals with Bacteroides led to gut inflammation, whereas Lactobacillus and fusiform bacteria did not result in inflammatory lesions. Klebsiella pneumonia, long hypothesized to be involved in the pathogenesis of AS based in part on higher serum levels of Immunoglobulin A (IgA) IgA antibodies [49] could not be confirmed by others [50] .
Treatment of HLA-B27 transgenic rats with SpA using prebiotics (compounds that induce growth or activity of commensals) has shown some benefit for colitis [13] , raising hope for future therapies aimed at altering the gut microbiome. There are a number of mechanisms by which HLA-B27 might alter the microbiome. For example, human monocytic cells expressing HLA-B27 exhibit impaired handling of Salmonella [51] , and exhibit reduced proliferative capacity against Lipopolysaccharide (LPS) LPS, suggesting that intracellular effects of HLA-B27 might be involved in shaping the intestinal microbiome. One study [52] reported that of 104 patients with spondyloarthropathies that were tested, polymorphisms in nucleotide-binding oligomerization domain containing 2 (NOD2) NOD2 were frequent in SpA patients with chronic gut inflammation (comparable to Crohn's patients), whereas, in SpA patients with acute gut inflammation or without gut inflammation, NOD2 polymorphisms were similar to the control population. Studies with HLA-B27 transgenic animals that are resistant to SpA-associated gut inflammation might be helpful in resolving these scenarios.
JUVENILE SPONDYLOARTHRITIS
Patients with a form of juvenile SpA classified as enthesitis-related arthritis, exhibit decreased abundance of Clostridium leptum [53 & ] similarly to AS patients [47] . Another member of the Clostridales family known as Fecalibacterium prausnitzii was also decreased in patients with juvenile SpA compared with healthy controls. Despite these differences, serum IgA and Immunoglobulin G (IgG) IgG antibody against F. prausnitzii and B. fragilis were similar between controls and patients. There is also some evidence of a cellular immune response to the outer membrane protein of Salmonella typhimurium in juvenile SpA patients compared with healthy controls [54] . Intriguingly, study of the microbiota of juvenile SpA patients revealed that patients could be stratified into two distinct clusters, one dominated by Bacteroides genus members, the other by Akkermansia muciniphila. The fact these may represent distinct disease subtypes remains an enticing possibility and serves to highlight that this approach may also be extended to the spectrum of SpA-like diseases.
PSORIATIC ARTHRITIS
Many patients with psoriasis and PsA have associated subclinical gut inflammation [55] . Decreased bacterial diversity due to lower abundances of several taxa were demonstrated [56] . The authors found Coprococcus to be inversely associated with psoriasis with or without arthritis (PsA), whereas a decline in relative abundance of Ruminococcus and Akkermansia were unique to PsA. This is of particular interest as Ruminococcus are also reduced in abundance in patients with IBD [57] . Moreover, the decreased abundance of Akkermansia in PsA contrasts to that of juvenile SpA, indicating distinct microbes may also drive the cause of these diseases.
Another gut commensal found in healthy populations, Alistipes, was lower in abundance in both PsA [56] and Crohn's disease [57] . Many of these microorganisms play a role in degrading mucus and producing SCFAs that influence gut homeostasis. A hallmark of dysbiosis in these individuals may be a loss of commensals, disrupting immune homeostasis.
INTESTINAL PERMEABILITY AND SPONDYLOARTHRITIS
Disruption of the intestinal epithelium has profound implications for the loss of mucosal tolerance. Further to the epithelium's role in providing physical and chemical barriers between microbe and host, the provision of mucus and other metabolites (e.g. fucose) to support the colonization of commensals is well described. Although a number of studies support increased intestinal permeability in SpA patients [58] , mirroring IBD populations [59] , this is not a universal observation [60] . Nonetheless, it is conceivable that transient or subclinical mucosal lesions may significantly disrupt local barrier integrity without overt systemic changes in intestinal permeability. The 'chicken-egg' dichotomy of inflammation and barrier function remains unresolved. Either local inflammation drives damage to the epithelium itself or dysbiotic changes that do not favor epithelial fitness (e.g. the loss of SCFAproducing bacteria), or a disrupted epithelium promotes a breakdown of mucosal homeostasis with resulting inflammation and dysbiosis (Fig. 1 ). Therefore, events in SpA leading to increased intestinal permeability may be spatiotemporally linked. Currently, HLA-B27 transgenic rats that develop subclinical and overt IBD provide a robust model to dissect some of these details. These transgenic animals exhibit background strain-dependent disease activity and severity, with Fischer (F344) animals exhibiting the most severe disease and Lewis animals less severely affected (manuscript in preparation). In contrast, HLA-B27 transgenic rats with the Dark Agouti background remain disease free, providing an opportunity to determine genetic and environmental factors that control gut inflammation.
Studies in HLA-B27 rats indicate intestinal inflammation and impaired barrier function occur concurrently [61] . Thus, development of barrier dysfunction, dysbiosis, and inflammation may be tightly linked both temporally and spatially. HLA-B27 expression is known to cause an unfolded protein response in APC triggered by protein accumulation and misfolding [62] . Although not detectable in ileal biopsies [63] , it is possible that individuals with HLA-B27 have a stress response in a subset of inflammatory cells. This could lead to either a disruption of the epithelial barrier, a local inflammatory response, or both culminating in the loss of barrier function and the loss of oral tolerance. It is conceivable that increased translocation of microbial products may prime the development of spondylitis-inducing immune cells that subsequently migrate to the periphery. Moreover, given that microbial products may induce peripheral inflammation themselves, for example, the curdlan/SKG model described above or endotoxininduced uveitis, translocated microbial products may contribute to the inflammatory cascade at extraintestinal sites [32, 64] .
CONCLUSION
Understanding the complexity and dynamic nature of the gut microbiome and its role in inflammatory disorders including SpA is a work in progress. During homeostasis, host-microbe interactions in the gut guide the normal development of host immune response, whereas microbial dysbiosis is implicated in disease pathogenesis. Currently, the broad spectrum of disease observed in both SpA patient populations and in animal models (e.g. the strain-specific development of disease in HLA-B27 transgenic rats) provides an opportunity to dissect genetic, environment, and microbiota-specific differences that underline SpA pathogenesis. Enticingly, antibiotic treatment, probiotic and prebiotic delivery, and even fecal transplant are all examples of how the microbiota may be readily manipulated. Moreover, the identification of SpA-associated microbiota phenotypes may aid in the diagnosis or prognosis of HLA-B27-dependent disease. In summary, microbiome research has the potential to revolutionize research, diagnosis, and treatment of SpA. . Importantly, changes to the intestinal microbiota itself may cause or contribute to inflammation. Host genetics may either create niches that promote dysbiosis, or directly alter immune responses to the 'normal' microbiota. These altered immune responses may manifest in hyperactive innate and adaptive immune responses that promote inflammation. Due to intimate epithelial-microbiota interactions, dysbiosis may also disrupt barrier function and intestinal homeostasis leading to inflammation, a process itself that may impair barrier integrity. Environmental triggers of dysbiosis are incompletely understood, but include diet and antibiotic use.
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